Feanix Biotechnologies
Feanix Biotechnologies, based in the United States, specializes in affordable genetic testing services for animals, focusing on cattle and birds. The company is part of the Y Combinator S23 batch and operates across multiple locations including Davis, CA, Asheville, NC, and New York, NY.
Company Locations
Feanix Biotechnologies operates out of three primary locations: Davis, CA, New York, NY, and Asheville, NC. The Asheville office is specifically situated at 39 Glendale Ave, Suite 102, Asheville, NC 28803. The company provides its services from Monday to Friday and accommodates various regions across the United States and Canada, as well as offering remote and partly remote services.
Contact Information for Feanix Biotechnologies
Feanix Biotechnologies can be contacted via phone at (530) 205-3588 or through email at info@feanixbio.com. The company maintains regular business hours from Monday to Friday and welcomes inquiries regarding its genetic testing services from its various offices.
Services Offered by Feanix Biotechnologies
Feanix Biotechnologies provides genetic testing services specifically designed for the animal breeding industry. These services include cattle and bird genetic testing, leveraging DNA and software to simplify farm genetics. Their offerings start at $10 and can be conducted with as little as a single hair or feather sample. The company is committed to advancing genetic testing to support sustainability, climate, genomics, and AI within agriculture.
Feanix Biotechnologies' Industry Focus
Feanix Biotechnologies is situated in the industrials industry, with a specific focus on agriculture. The company specializes in genetic testing advancements for the animal breeding industry. This aligns with its broader commitment to sustainability, climate, genomics, and AI within agriculture, aiming to innovate and simplify farm genetics using modern DNA and software technologies.
Feanix Biotechnologies and Y Combinator
Feanix Biotechnologies is part of the Y Combinator S23 batch, indicating its early stage in business development. Participation in this prestigious startup accelerator highlights the company's potential for growth and innovation within the genetic testing market for animal breeding.